Fig. 1From: DNA methylation landscape reveals LIN7A as a decitabine-responsive marker in patients with t(8;21) acute myeloid leukemiaa Comparison of the inhibition effect of different decitabine (DAC) concentrations on acute myeloid leukemia (AML) cell lines with (AE positive) or without (AE negative) t(8;21) translocation. b Study flow chart. Overview of the study cohort and follow-up analyses to identify DAC-sensitive regions in t(8;21) AMLBack to article page